TransMedics (TMDX) · page 319 of 342
The slide uses expert testimony to frame TransMedics as an overpriced incumbent being disrupted by a cheaper, established European technique (NRP).
Research note · villain_critique · name_villain · dense density
Slide locked Sign in to view
Slide schematic 3/6
callout 0/1 list 1/1 metric 0/1 paragraph 1/1 quote 0/1 source-note 1/1
3 without position callout 1 · metric 1 · quote 1
calloutmetric · primaryquote
Components 6
callout bullet primary paragraph quote source-note
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1